A Toxic Synergy: Organophosphorus Exposure in the Context of Alcohol and Benzodiazepine Dependence

Abstract

Organophosphorus (OP) poisoning remains a major toxicological emergency in low- and middle-income countries, particularly in agricultural regions where pesticide accessibility is high. Global estimates suggest approximately 3 million pesticide poisonings annually, with mortality approaching 200,000 deaths per year—most resulting from intentional ingestion [1,2]. In South Asian settings, OP poisoning continues to exert a substantial burden on emergency and critical care services. The principal mechanism of OP toxicity is irreversible inhibition of acetylcholinesterase, resulting in excessive acetylcholine accumulation and a cholinergic crisis. Cardiovascular manifestations are common and clinically significant. Intense parasympathetic stimulation, autonomic imbalance, electrolyte disturbances, and direct myocardial toxicity contribute to bradyarrhythmias, tachyarrhythmias, conduction delays, QT prolongation, and, in severe cases, malignant ventricular arrhythmias [3–6]. QT prolongation is particularly concerning, as it predisposes to torsades de pointes and sudden cardiac death. Alcohol and benzodiazepines independently exert measurable electrophysiological effects. Acute alcohol intoxication has been associated with atrial fibrillation, QT prolongation, P-wave changes, and catecholamine-mediated electrical instability [7–9]. Benzodiazepine overdose has been linked to PR, QRS, and QTc prolongation, as well as repolarization abnormalities [10]. When these agents coexist with OP toxicity, the potential for additive—or even synergistic—cardiotoxicity becomes biologically plausible. In this issue of the journal, Uddin and Warsi report an important observation: while 46% of patients with OP poisoning alone demonstrated abnormal ECG findings, the prevalence increased to approximately 66–70% in those with alcohol or benzodiazepine dependence [11]. These data suggest that substance addiction may meaningfully amplify electrical instability in OP poisoning. The concept of toxic synergy is well established in cardiovascular pharmacology. When two agents independently affect cardiac conduction or repolarization—particularly via different mechanistic pathways—their combined effect frequently exceeds simple additivity. A recent example includes the combination of hydroxychloroquine and azithromycin during the early COVID-19 pandemic, which resulted in greater QT prolongation and higher arrhythmic risk than either drug alone [12]. The findings presented by Uddin and Warsi align with this broader principle of electrophysiologic vulnerability under dual toxic stress. However, several methodological considerations merit discussion. First, baseline ECG data were not reported. Chronic alcohol or benzodiazepine dependence may already be associated with conduction abnormalities prior to OP exposure. Without baseline tracings, it remains unclear whether the observed abnormalities represent de novo changes or exacerbation of pre-existing electrical instability. Second, the study does not clarify whether patients with substance addiction presented with concurrent acute intoxication (i.e., alcohol or benzodiazepine ingestion at the time of OP poisoning). Co-intoxication could independently influence conduction parameters and potentially confound interpretation. Third, addiction-related behavioral disinhibition may result in ingestion of larger quantities of OP compounds. If addicted patients consumed higher toxic doses, the observed ECG abnormalities may partially reflect dose severity rather than purely pharmacodynamic synergy. Future investigations incorporating toxicological quantification and serum cholinesterase levels would strengthen causal inference. Despite these limitations, the clinical implications are important. Addiction history may represent an under-recognized risk modifier in OP poisoning. From a cardiology perspective, patients with known alcohol or benzodiazepine dependence who present with OP ingestion may warrant: Early and continuous ECG monitoring Serial QTc assessment Aggressive correction of electrolyte disturbances Lower thresholds for ICU admission Risk stratification protocols for OP poisoning may benefit from formally incorporating substance addiction status as a prognostic variable. The work by Uddin and Warsi highlights a clinically relevant and biologically plausible interaction between organophosphorus toxicity and substance dependence. Their findings reinforce an essential principle in cardiovascular toxicology: when multiple agents converge on myocardial conduction and repolarization pathways, the resultant electrical instability may be amplified. In regions where OP poisoning and substance addiction coexist, clinicians must anticipate compounded cardiotoxic risk. Addiction history should not be viewed merely as a social variable—but as a potential electrophysiological risk factor. Future prospective studies integrating baseline ECG data, toxic dose quantification, and mortality outcomes are warranted to clarify the magnitude of this interaction. Until then, heightened vigilance remains the prudent course. References International Programme on Chemical Safety, World Health Organization (WHO) Epidemiology of Pesticide Poisoning: Harmonized Collection of Data on Human Pesticide Exposure in Selected Countries. Geneva, Switzerland: WHO Press; 2004. Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet. 2008;371(9612):597-607. DOI: 10.1016/S0140-6736(07)61202-1 Khandare S, Madavi T, Bhagwat N, Shingade P. Study of cardiovascular complications and in hospital outcomes in patients of organophosphorus compound poisoning in tertiary care hospital. Eur J of Cardiovasc Med. 2025;15(4):25-32. Saadeh AM, Farsakh NA, al-Ali MK. Cardiac manifestations of acute carbamate and organophosphate poisoning. Heart. 1997;77(5):461-4. DOI: 10.1136/hrt.77.5.461 Vijayakumar S, Fareedullah M, Ashok Kumar E, Mohan Rao K. A prospective study on electrocardiographic findings of patients with organophosphorus poisoning. Cardiovasc Toxicol. 2011;11(2):113-7. DOI: 10.1007/s12012-011-9104-4 Pannu AK, Bhalla A, Vishnu RI, Garg S, Dhibar DP, Sharma N, et al. Cardiac injury in organophosphate poisoning after acute ingestion. Toxicol Res (Camb). 2021;10(3):446-52. DOI: 10.1093/toxres/tfab036 Raheja H, Namana V, Chopra K, Sinha A, Gupta SS, Kamholz S, et al. Electrocardiogram Changes with Acute Alcohol Intoxication: A Systematic Review. Open Cardiovasc Med J. 2018;12:1-6. DOI: 10.2174/1874192401812010001 James TN, Bear ES. Effects of ethanol and acetaldehyde on the heart. Am Heart J. 1967;74(2):243-55. DOI: 10.1016/0002-8703(67)90284-0 Perman ES. The effect of ethyl alcohol on the secretion from the adrenal medulla in man. Acta Physiol Scand. 1958;44(3-4):241-7. DOI: 10.1111/j.1748-1716.1958.tb01624.x Kazemzadeh N, Mohammadi S, Emamhadi M, Amirfarhangi A, Sanaei-Zadeh H. Electrocardiographic Manifestations of Benzodiazepine Toxicity. Iranian J Toxicol. 2014;7(23):952-5. Uddin SF, Warsi J. Electrocardiographic Alterations in Organophosphorus Poisoning: A Comparative Study among Addicted and Non-Addicted Males in Hyderabad. Pak Heart J. 2026;59(01):72-77. DOI: 10.47144/phj.v59i1.3134 Li W, Luo X, Poetsch MS, Oertel R, Nichani K, Schneider M, et al. Synergistic Adverse Effects of Azithromycin and Hydroxychloroquine on Human Cardiomyocytes at a Clinically Relevant Treatment Duration. Pharmaceuticals (Basel). 2022;15(2):220. DOI: 10.3390/ph15020220